- Home
- BHC
as 05-09-2025 4:00pm EST
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | QUEBEC |
| Market Cap: | 2.0B | IPO Year: | N/A |
| Target Price: | $7.20 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.96 - $9.85 | Next Earning Date: | 04-30-2025 |
| Revenue: | $9,731,000,000 | Revenue Growth: | 8.53% |
| Revenue Growth (this year): | 4.92% | Revenue Growth (next year): | 2.36% |
Latest Bausch Health Companies Inc. News
BHC Breaking Stock News: Dive into BHC Ticker-Specific Updates for Smart Investing
Medical Device Network
2 days ago
Bausch + Lomb gains CE Mark approval for full range of vision intraocular lens
MT Newswires
2 days ago
Bausch + Lomb Gets European CE Mark for LuxLife Vision Intraocular Lens
Insider Monkey
2 days ago
Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential
MT Newswires
3 days ago
Bausch + Lomb Says Received European CE Mark Approval for Preloaded LuxLife Full Range of Vision Intraocular Lens
MT Newswires
4 days ago
Bausch Health Up 3.5% In US Premarket As Says New Analysis Suggests efficacy of Xifaxan
ACCESS Newswire
4 days ago
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
Simply Wall St.
8 days ago
Bausch Health Companies First Quarter 2025 Earnings: EPS Misses Expectations
MT Newswires
8 days ago
RBC on Bausch Health's Q1
Compare BHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BHC Bausch Health Companies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.